tiprankstipranks
Trending News
More News >
Hypera SA (HYPMY)
OTHER OTC:HYPMY

Compare Hypera SA (HYPMY) vs. Competitors

Compare
9 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Hypera SA
$4.31
$3.07B
20.54
53.18%
Perrigo Company
$14.14
$1.97B
-37.54
-43.64%
1 Buy
1 Hold
0 Sell
Moderate Buy
Supernus Pharmaceuticals
$48.40
$2.80B
-142.02
29.55%
4 Buy
1 Hold
0 Sell
Strong Buy
ANI Pharmaceuticals
$79.88
$1.80B
48.99
37.94%
3 Buy
1 Hold
0 Sell
Strong Buy
Indivior
$35.00
$4.37B
35.29
202.22%
5 Buy
0 Hold
0 Sell
Strong Buy
Amneal Pharmaceuticals
$14.25
$4.46B
1,003.52
74.21%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HYPMY
Hypera SA
4.94
1.74
54.47%
PRGO
Perrigo Company
14.14
-9.61
-40.45%
SUPN
Supernus Pharmaceuticals
48.40
8.40
21.00%
ANIP
ANI Pharmaceuticals
79.88
21.29
36.34%
INDV
Indivior
35.45
24.05
210.96%
AMRX
Amneal Pharmaceuticals
14.25
6.26
78.35%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts